Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
| Website | http://psylo.bio |
| Employees | 27 (2 on RocketReach) |
| Industry | Biotechnology |
| Keywords | Psychedelic Medicine, Psychedelic Therapeutics, Psychedelic Research, Drug Development, Pharmaceutical Research, Drug Discovery, Mental Health Treatment, Biotechnology, Clinical Trials, Depression Treatment, Anxiety Treatment, Neurological Disorders, Breakthrough Therapies, New Drug Applications, Mental Wellness, Compassionate Use, Phase 1 Trials |
| Competitors | Pinnacle Foods, Schwabe North America, Garden of Life, True Botanicals, HUM Nutrition, Four Sigmatic, Om Mushroom Superfood, LumiBio, Canine Matrix, Mushroom Revival Inc. +21 more (view full list) |
Looking for a particular Psylo employee's phone or email?
Joshua Ismin is the Co-founder, CEO of Psylo.
2 people are employed at Psylo.
Psylo is based in Sydney, New South Wales.